Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

It’s Time to Secure Those Profits You Earned from Novavax

While NVAX stock had an excellent run, the vaccination market is practically saturated, meaning investors should consider profit-taking.

Hyliion Holdings Stock Isn’t as Cheap as It Looks as Costs Rise and Hope Fades

Trouble continues to compound for HYLN stock as SPAC hype fades. The company is predicting much greater results than anyone else.

UiPath Is Losing Money on a Cash Flow Basis Leaving It Lost In Its Way

PATH stock is likely to take another 33% drop to at least $33.59, as its overvalued price-to-sales multiple deflates.

Olaplex Is Overvalued As None of the IPO Proceeds Go to the Company

Olaplex is overvalued as none of the IPO proceeds go to the company. Investors will see through the actions of the private equity fund and value OLPX stock significantly lower.

This Ocugen Stock Rally Makes Little Sense, But Watch Out Going Short

Highly volatile, with a tendency to make unwarranted moves higher, it's best to not go long (or short) OCGN stock.

CrowdStrike Stock Has Had Its Run, But There Are Much Better Security Plays

CrowdStrike has many positive attributes, including strong partners and a rapidly growing business. But the valuation of CRWD stock is very high.

Nothing Suggests Hyliion Stock Can Charge Back Up to Past Prices

As it falls short of expectations, and with more signs of it floundering further, it's best to stay away from HYLN stock.

WISH Stock Is a Bad Risk in a Sea of Better Speculative Growth Bets

Wish.com parent company ContextLogic (NASDAQ:WISH) stock has been a disaster since its initial public offering. Wish went public at an IPO price of $24 in…

China’s President Is the X Factor for Alibaba Stock

The heavy-handedness and unpredictability of China's president, Xi Jinping, makes BABA stock too risky, even after its shares have fallen meaningfully.

Ocugen Is a Strong Sell, Vaccine Unlikely to Find Commercial Success

Ocugen has historically had a terrible track record. There's little reason to think its current vaccine effort will end any better for OCGN stock.

7 Growth Stocks That You Should Sell in October

The market has been generous for quite a while but now the economic winds are shifting and finding good growth stocks is harder.

Intel Stock Looks Doomed to Continue Its Downward Journey

Intel is struggling in the industry amid rising competition. Third quarter results could be disappointing and it is best to avoid INTC stock.

OpenDoor Stock Is Heading for a Serious Pullback Sooner Than You Think

Over the next three months to one year, OPEN stock could easily undergo a nasty correction, driven by a sharp drop in the demand for housing.

Should Investors Buy Fiverr Stock After Its Big Drop?

Those who think FVRR stock seems like a bargain right now should take a serious look at the company's weak spots.

It May Take Time, But Meta Materials Stock Will Decline in Price

Dilution and disappointment will ultimately push MMAT stock to a price more in line with its underlying value despite its lofty ambitions.

Avoid Camber Energy As Its Revenue Growth Potential Remains a Mystery

The speculative rally in CEI stock seems to be over. There are too many uncertainties regarding the company's revenue growth potential.

ContextLogic’s Expensive Marketing Makes Profit a Challenge

ContextLogic looks like a falling knife. Its huge marketing expenses are eating away at its profits and forcing WISH stock down.

Don’t Count Lordstown Motors Among Your EV Stocks to Buy

Don’t fall for the low RIDE stock price. The Lordstown is in such dire straits it sold its factory for cash to keep the lights on until 2022.

AST SpaceMobile Has a Great Business Plan But Its Execution Will Not Be Easy

ASTS stock is a bold and very risky vision to turn space into a giant, cellular broadband network. Its path to success is paved with risk.